Related Experiment Video
Updated: Feb 16, 2026

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
Published on: August 1, 2025
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening
Marlise R Luskin1,2, Marie N Discenza2,3, Sarah Rae Easter2,4
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy.Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.
cfDNA sequencing for fetal aneuploidy may detect chromosomal abnormalities representative of maternal malignancy.Maternal malignancy must be considered when abnormal cfDNA sequencing for fetal aneuploidy is associated with normal fetal karyotype.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
DNA as a Genetic Template
DNA as a Genetic Template
Animal Mitochondrial Genetics
What is Genetic Engineering?
From DNA to Protein

